Skip to main content
Department of Pharmaceutics

Research

Our research plan for the next 5 years (2019-2023):

Main research activities

Several active research groups in the department are engaged with different aspects of pharmaceutics. The research is directed towards high quality innovative topics aiming to publish applied articles.

The research plan in the period from 2019 till 2023 is still focusing on three distinct areas:

  1. Nanotechnology as a promising area of pharmaceutical science is a target for formulation of many drugs.
  2. Preformulation studies to improve the characteristics of drugs and/or dosage forms and development of more acceptable dosage forms.
  3. Targeted drug delivery systems

 

 

# Title Research Year
21 Externally Triggered Novel Rapid-Release Sonosensitive Folate-Modified Liposomes for Gemcitabine: Development and Characteristics 2021
22 Development and Evaluation of Letrozole‑Loaded Hyaluronic Acid/Chitosan‑Coated Poly(d,l‑lactide‑co‑glycolide) Nanoparticles 2021
23 Development and Evaluation of Letrozole‑Loaded Hyaluronic Acid/Chitosan‑Coated Poly(d,l‑lactide‑co‑glycolide) Nanoparticles 2021
24 Impact of Biocompatible Poly (ethylene glycol)-block-Poly (ε-caprolactone) Nano-Micelles on the Antifungal Efficacy of Voriconazole 2021
25 Tailoring Additively Manufactured Titanium Implants for Short-Time Pediatric Implantations with Enhanced Bactericidal Activity 2021
26 Betaxolol‐loaded Niosomes Integrated Within pH‐sensitive in situ Forming
Gel for Management of Glaucoma
2021
27 Spanlastics as an efficient delivery system for the enhancement of thymoquinone anticancer efficacy: Fabrication and cytotoxic studies against breast cancer cell lines 2021
28 Betaxolol‐loaded Niosomes Integrated Within pH‐sensitive in situ Forming
Gel for Management of Glaucoma
2021
29 Advancing of 3D-Printed Titanium Implants with Combined Antibacterial Protection Using Ultrasharp Nanostructured Surface and Gallium-Releasing Agents 2021
30 Antibiofilm and antivirulence potential of silver nanoparticles against multidrug‐resistant Acinetobacter baumannii 2021